Literature DB >> 31933881

A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.

Zhi-Hong Xu1, Hui Wang2, Xiao-Yang Ji1, Fei-Xu Zhang2, Bei-Li Gao3, Jia-An Hu1, Jing Zheng2.   

Abstract

Lung adenocarcinoma (LUAD) is the most common histologic subtype of lung cancer. Previous research has shown heterogeneity in lung cancer, with the parallel existence of multiple subclones characterized by their own specific mutational landscape. The aim of our study was to gain insight into the evolutionary pattern of lung cancer by investigating the genomic heterogeneity between a nodule and its distant tumor. Luckily, we obtained nodule and tumor samples derived from surgery and a blood sample from a single patient. The samples are very unique, for tissues with the same genetic background from nodules to malignant tumors are rarely available and require precise micro-cutting. In this study, we performed whole-genome sequencing of these two samples, to identify novel candidate driver genes associated with LUAD. The nodule and tumor were found to have common significant ubiquitin-specific protease 40 (USP40) mutations, indicating an important driver role for the gene. Moreover, we also observed the two novel candidate driver genes ASCL5 and CAPNS1 in the LUAD sample. In summary, we pinpoint the predominant mutations in LUAD by WES, highlighting the substantial genetic alterations contributing to LUAD tumorigenesis. This may provide a better understanding of the clonal evolution during tumor development. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Lung adenocarcinoma tumorigenesis; USP40; subclonal mutations

Year:  2019        PMID: 31933881      PMCID: PMC6945189     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

Review 1.  Clinical practice. The solitary pulmonary nodule.

Authors:  David Ost; Alan M Fein; Steven H Feinsilver
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

2.  The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.

Authors:  Xiao-Xin Sun; Xia He; Li Yin; Masayuki Komada; Rosalie C Sears; Mu-Shui Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

3.  Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.

Authors:  Jie Gu; Feng-kai Xu; Guang-yin Zhao; Chun-lai Lu; Zong-wu Lin; Jian-yong Ding; Di Ge
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

Review 4.  Deubiquitinases in cancer: new functions and therapeutic options.

Authors:  J M Fraile; V Quesada; D Rodríguez; J M P Freije; C López-Otín
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

5.  Mice heterozygous for Atp10c, a putative amphipath, represent a novel model of obesity and type 2 diabetes.

Authors:  Madhu S Dhar; Carla S Sommardahl; Tanisa Kirkland; Sarah Nelson; Robert Donnell; Dabney K Johnson; Lawrence W Castellani
Journal:  J Nutr       Date:  2004-04       Impact factor: 4.798

Review 6.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

7.  [Differential expression of USP2, USP14 and UBE4A between ovarian serous cystadenocarcinoma and adjacent normal tissues].

Authors:  Ying Yang; Jian-qing Hou; Lu-yun Qu; Gui-qing Wang; Hong-wei Ju; Zhi-wei Zhao; Zhen-hai Yu; Hui-jun Yang
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2007-06

Review 8.  Targeting growth factors in lung cancer.

Authors:  Philip S Hodkinson; Alison Mackinnon; Tariq Sethi
Journal:  Chest       Date:  2008-05       Impact factor: 9.410

9.  The epidermal growth factor receptor (EGRF) in lung cancer.

Authors:  Enric Carcereny; Teresa Morán; Laia Capdevila; Sara Cros; Laia Vilà; Maria de Los Llanos Gil; Jordi Remón; Rafael Rosell
Journal:  Transl Respir Med       Date:  2015-02-24

10.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.

Authors:  Kristian Cibulskis; Michael S Lawrence; Scott L Carter; Andrey Sivachenko; David Jaffe; Carrie Sougnez; Stacey Gabriel; Matthew Meyerson; Eric S Lander; Gad Getz
Journal:  Nat Biotechnol       Date:  2013-02-10       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.